Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
See Latest ArticlesLeukotriene E4-induced pulmonary inflammation is mediated by the P2Y12 receptor
Journal of Experimental Medicine, 10/28/09
Xing W et al. – The effects of LTE4 on P2Y12 in the airway were abrogated by platelet depletion. Thus, the P2Y12 receptor is required for proinflammatory actions of the stable abundant mediator LTE4 and is a novel potential therapeutic target for asthma.
Today in Asthma/Atopy...keeping you current
Receive free subspecialty "5-minute updates" via email
Anti-inflammatory drug therapy in asthma
Paediatric Respiratory Reviews, 11/02/09
An Umbrella Review: Corticosteroid Therapy for Adults with Acute Asthma
American Journal of Medicine, 10/27/09
Montelukast in the treatment of asthma and beyond
Expert Review of Clinical Immunology, 11/23/09
Sponsor
Article Search
Sponsor